HIV and AIDS

Cards (16)

  • Major cellular targets for HIV-1 are CD4 lymphocytes and macrophages.
  • Major cellular targets for HIV-1 are CD4 lymphocytes and macrophages:
    • As CD4 count falls, increased risk of atypical/recurrent/prolonged infections
    • Increased risk of AIDS-related cancers
    • Increased risk of organ-specific HIV-related complications
    • As viral load increases, CD4 count will fall, HIV-related conditions will increase, and infectivity increases
  • Routes of acquisition of HIV:
    • Sexual intercourse (sex work, any sexual encounter)
    • IV drug use
    • Mother to child transmission
    • Infected blood products
    • Occupational
  • Risk reduction of HIV acquisition:
    • Sexual transmission
    • Condoms, sero-sorting, sero-positioning, regular STI screening, TasP (treatment as prevention), PREP (pre-exposure prophylaxis - giving drugs as a preventative measure to someone who is not infected)
    • IV drug use
    • Needle exchange programmes
    • Mother to child transmission
    • Ante-natal screening, TasP, birth plan, PREP for baby, avoid breast-feeding
    • Blood products
    • BBV screening
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • Respiratory
    • Tuberculosis
    • Bacterial pneumonia
    • Pneumocystis
    • Aspergillosis
    • Neurology
    • Cerebral toxoplasmosis
    • Aseptic meningitis/encephalitis
    • Primary cerebral lymphoma
    • Cerebral abscess
    • Cryptococcal meningitis
    • Peripheral neuropathy
    • Dementia
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • Dermatology
    • Kaposi's sarcoma
    • Severe or recalcitrant seborrhoeic dermatitis
    • Severe or recalcitrant psoriasis
    • Herpes zoster
    • Gastroenterology
    • Persistent cryptosporidiosis
    • Oral candidiasis
    • Oral hairy leukoplakia
    • Chronic diarrhoea
    • Weight loss
    • Salmonella
    • Shigella or campylobacter
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • Hepatitis
    • B infection
    • C infection
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • Oncology
    • Non-Hodgkin's lymphoma
    • Anal cancer or anal intraepithelial dysplasia
    • Lung cancer
    • Seminoma
    • Head and neck cancer
    • Hodgkin's lymphoma
    • Castleman's disease
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • Gynaecology
    • Cervical cancer
    • Vaginal intraepithelial neoplasia
    • Cervical intraepithelial neoplasia
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • Haematology
    • Thrombocytopenia
    • Neutropenia
    • Lymphopenia
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • Ophthalmology
    • Cytomegalovirus retinitis
    • Infective retinal diseases including herpes viruses and toxoplasma
    • Unexplained retinopathy
  • Clinical indicator diseases for adult HIV infection - if a patient has any of these things, they should get a HIV test:
    • ENT
    • Lymphadenopathy of unknown cause
    • Chronic parotitis
    • Lymphoepithelial parotid cysts
    • Mononucleosis-like syndrome
    • Pyrexia of unknown origin
    • Sexually transmitted infection
  • HIV treatment:
    • When to start:
    • BHIVA guidelines suggest start on diagnosis rather than CD4: <350 (START study)
    • Less AIDS-related complications
    • Reduced all cause mortality
    • Reduced transmission
    • What to start:
    • 2x NRTI + NNRTI/boosted PI/II
    • NRTI = nucleoside/nucleotide reverse transcriptase inhibitor (an antiretroviral drug)
  • HAART (highly active antiretrovial therapy):
    • Aims
    • Inhibit viral replication
    • Present high genetic barrier to resistance
    • At least 3 drugs
    • At least 2 classes
    • Allow CD4 count to recover
    • Target for HAART
    • Cell entry
    • Co-receptor antagonism - CCR5
    • Fusion inhibition
    • Enzyme inhibition
    • Reverse transcriptase - NRTi/NNRTi
    • Integrase
    • Protease
  • HIV in pregnancy - there's an increased risk of transmission if:
    • High viral load
    • Advanced immunodeficiency
    • Sero-conversion during pregnancy
    • STI infection
    • IVDU (intravenous drug use)/Hepatitis C
    • Malnutrition
    • Complicated labour
  • Key issues in HIV care:
    • Late diagnosis
    • Stigma
    • Adherence
    • Interactions
    • Partner notification and testing
    • Prevention of transmission
    • Management of co-morbidities
    • Conception and pregnancy planning